Skip to main content
. 2019 Aug 14;181(5):967–975. doi: 10.1111/bjd.17919

Figure 2.

Figure 2

Efficacy analysis population and subpopulations. ITT, intention to treat; ADA, adalimumab; ew, weekly dosing; pbo, placebo; eow, every‐other‐week dosing; HiSCR, Hidradenitis Suppurativa Clinical Response; AN, total abscess and inflammatory nodule count.